EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Federated Learning in Computational Toxicology: An Industrial Perspective on the Effiris Hackathon

Davide Bassani iD, Alessandro Brigo, Andrea Andrews-Morger iD

Chemical Research in Toxicology · 18.09.2023 · 36 (9) · 1503-1517

DOI: 10.1021/acs.chemrestox.3c00137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, online erschienen am 16.08.2023. Verfasst von Davide Bassani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland. Hauptthemen laut MEDLINE: Algorithms, Spiders. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In silico approaches have acquired a towering role in pharmaceutical research and development, allowing laboratories all around the world to design, create, and optimize novel molecular entities with unprecedented efficiency. From a toxicological perspective, computational methods have guided the choices of medicinal chemists toward compounds displaying improved safety profiles. Even if the recent advances in the field are significant, many challenges remain active in the on-target and off-target prediction fields. Machine learning methods have shown their ability to identify molecules with safety concerns. However, they strongly depend on the abundance and diversity of data used for their training. Sharing such information among pharmaceutical companies remains extremely limited due to confidentiality reasons, but in this scenario, a recent concept named "federated learning" can help overcome such concerns. Within this framework, it is possible for companies to contribute to the training of common machine learning algorithms, using, but not sharing, their proprietary data. Very recently, Lhasa Limited organized a hackathon involving several industrial partners in order to assess the performance of their federated learning platform, called "Effiris". In this paper, we share our experience as Roche in participating in such an event, evaluating the performance of the federated algorithms and comparing them with those coming from our in-house-only machine learning models. Our aim is to highlight the advantages of federated learning and its intrinsic limitations and also suggest some points for potential improvements in the method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsSpidersAnimalsLaboratoriesMachine LearningPharmaceutical Preparations

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Pharmaceutical Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.

ORCID-Profile: Davide Bassani, Andrea Andrews-Morger

Zitieren

APA

Bassani, D., Brigo, A., & Andrews-Morger, A. (2023). Federated Learning in Computational Toxicology: An Industrial Perspective on the Effiris Hackathon. Chemical Research in Toxicology, 36(9), 1503-1517. https://doi.org/10.1021/acs.chemrestox.3c00137

Vancouver

Bassani D, Brigo A, Andrews-Morger A. Federated Learning in Computational Toxicology: An Industrial Perspective on the Effiris Hackathon. Chemical Research in Toxicology. 2023;36(9):1503-1517. doi:10.1021/acs.chemrestox.3c00137

BibTeX
@article{Bassani2023,
  author = {Bassani, Davide and Brigo, Alessandro and Andrews-Morger, Andrea},
  title = {Federated Learning in Computational Toxicology: An Industrial Perspective on the Effiris Hackathon},
  journal = {Chemical Research in Toxicology},
  year = {2023},
  volume = {36},
  number = {9},
  pages = {1503--1517},
  doi = {10.1021/acs.chemrestox.3c00137}
}
Kostenlos starten →